462 related articles for article (PubMed ID: 17911591)
1. PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissues.
Keir ME; Freeman GJ; Sharpe AH
J Immunol; 2007 Oct; 179(8):5064-70. PubMed ID: 17911591
[TBL] [Abstract][Full Text] [Related]
2. Cutting Edge: Programmed death (PD) ligand-1/PD-1 interaction is required for CD8+ T cell tolerance to tissue antigens.
Martin-Orozco N; Wang YH; Yagita H; Dong C
J Immunol; 2006 Dec; 177(12):8291-5. PubMed ID: 17142723
[TBL] [Abstract][Full Text] [Related]
3. Intestinal tolerance is converted to autoimmune enteritis upon PD-1 ligand blockade.
Reynoso ED; Elpek KG; Francisco L; Bronson R; Bellemare-Pelletier A; Sharpe AH; Freeman GJ; Turley SJ
J Immunol; 2009 Feb; 182(4):2102-12. PubMed ID: 19201863
[TBL] [Abstract][Full Text] [Related]
4. Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation.
Bu DX; Tarrio M; Maganto-Garcia E; Stavrakis G; Tajima G; Lederer J; Jarolim P; Freeman GJ; Sharpe AH; Lichtman AH
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1100-7. PubMed ID: 21393583
[TBL] [Abstract][Full Text] [Related]
5. Active dissemination of cellular antigens by DCs facilitates CD8
Gurevich I; Feferman T; Milo I; Tal O; Golani O; Drexler I; Shakhar G
Eur J Immunol; 2017 Oct; 47(10):1802-1818. PubMed ID: 28872666
[TBL] [Abstract][Full Text] [Related]
6. Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells.
Goldberg MV; Maris CH; Hipkiss EL; Flies AS; Zhen L; Tuder RM; Grosso JF; Harris TJ; Getnet D; Whartenby KA; Brockstedt DG; Dubensky TW; Chen L; Pardoll DM; Drake CG
Blood; 2007 Jul; 110(1):186-92. PubMed ID: 17392506
[TBL] [Abstract][Full Text] [Related]
7. The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo.
Paterson AM; Brown KE; Keir ME; Vanguri VK; Riella LV; Chandraker A; Sayegh MH; Blazar BR; Freeman GJ; Sharpe AH
J Immunol; 2011 Aug; 187(3):1097-105. PubMed ID: 21697456
[TBL] [Abstract][Full Text] [Related]
8. Programmed cell death 1 (PD-1) regulates the effector function of CD8 T cells via PD-L1 expressed on target keratinocytes.
Okiyama N; Katz SI
J Autoimmun; 2014 Sep; 53():1-9. PubMed ID: 25047812
[TBL] [Abstract][Full Text] [Related]
9. Target-dependent B7-H1 regulation contributes to clearance of central nervous system infection and dampens morbidity.
Phares TW; Ramakrishna C; Parra GI; Epstein A; Chen L; Atkinson R; Stohlman SA; Bergmann CC
J Immunol; 2009 May; 182(9):5430-8. PubMed ID: 19380790
[TBL] [Abstract][Full Text] [Related]
10. CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition.
Barber DL; Mayer-Barber KD; Feng CG; Sharpe AH; Sher A
J Immunol; 2011 Feb; 186(3):1598-607. PubMed ID: 21172867
[TBL] [Abstract][Full Text] [Related]
11. Intestinal epithelial antigen induces mucosal CD8 T cell tolerance, activation, and inflammatory response.
Liu Z; Lefrançois L
J Immunol; 2004 Oct; 173(7):4324-30. PubMed ID: 15383561
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites.
Kobori H; Hashiguchi M; Piao J; Kato M; Ritprajak P; Azuma M
Immunology; 2010 Jul; 130(3):363-73. PubMed ID: 20141543
[TBL] [Abstract][Full Text] [Related]
13. Targeting NKT cells and PD-L1 pathway results in augmented anti-tumor responses in a melanoma model.
Durgan K; Ali M; Warner P; Latchman YE
Cancer Immunol Immunother; 2011 Apr; 60(4):547-58. PubMed ID: 21240487
[TBL] [Abstract][Full Text] [Related]
14. Targeting the gut vascular endothelium induces gut effector CD8 T cell responses via cross-presentation by dendritic cells.
Bourges D; Zhan Y; Brady JL; Braley H; Caminschi I; Prato S; Villadangos JA; Lew AM
J Immunol; 2007 Nov; 179(9):5678-85. PubMed ID: 17947639
[TBL] [Abstract][Full Text] [Related]
15. Dual control of antitumor CD8 T cells through the programmed death-1/programmed death-ligand 1 pathway and immunosuppressive CD4 T cells: regulation and counterregulation.
Currie AJ; Prosser A; McDonnell A; Cleaver AL; Robinson BW; Freeman GJ; van der Most RG
J Immunol; 2009 Dec; 183(12):7898-908. PubMed ID: 20007574
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
[TBL] [Abstract][Full Text] [Related]
17. Tumor-induced immune suppression of in vivo effector T-cell priming is mediated by the B7-H1/PD-1 axis and transforming growth factor beta.
Wei S; Shreiner AB; Takeshita N; Chen L; Zou W; Chang AE
Cancer Res; 2008 Jul; 68(13):5432-8. PubMed ID: 18593946
[TBL] [Abstract][Full Text] [Related]
18. Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway.
Haspot F; Fehr T; Gibbons C; Zhao G; Hogan T; Honjo T; Freeman GJ; Sykes M
Blood; 2008 Sep; 112(5):2149-55. PubMed ID: 18577709
[TBL] [Abstract][Full Text] [Related]
19. LAG-3, TGF-β, and cell-intrinsic PD-1 inhibitory pathways contribute to CD8 but not CD4 T-cell tolerance induced by allogeneic BMT with anti-CD40L.
Lucas CL; Workman CJ; Beyaz S; LoCascio S; Zhao G; Vignali DA; Sykes M
Blood; 2011 May; 117(20):5532-40. PubMed ID: 21422469
[TBL] [Abstract][Full Text] [Related]
20. Cross-presentation of male seminal fluid antigens elicits T cell activation to initiate the female immune response to pregnancy.
Moldenhauer LM; Diener KR; Thring DM; Brown MP; Hayball JD; Robertson SA
J Immunol; 2009 Jun; 182(12):8080-93. PubMed ID: 19494334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
